Malaria

Current MPAC members


Professor Brian Greenwood

Manson Professor of Clinical Tropical Medicine, London School of Hygiene and Tropical Medicine, London, England

Brian Greenwood qualified in medicine at the University of Cambridge, United Kingdom in 1962. Following house-officer appointments in London, he spent 3 years in Western Nigeria as a medical registrar and research fellow at University College Hospital, Ibadan. After receiving further training in clinical immunology in the UK, he returned to Nigeria in 1970, this time to help in establishing a new medical school at Ahmadu Bello University, Zaria where he developed his research interests in malaria and meningococcal disease whilst continuing to teach and practice clinical medicine.

In 1980, he moved to the UK Medical Research Council Laboratories in The Gambia which he directed for the next 15 years. In The Gambia, he helped to establish a multi-disciplinary research programme which focused on some of the most important infectious diseases prevalent in The Gambia and neighbouring countries such as malaria, pneumonia, measles, meningitis, hepatitis and HIV2. Work undertaken during this period included demonstration of the efficacy of insecticide treated bednets in preventing death from malaria in African children and demonstration of the major impact of Haemophilus influenzae type b and pneumococcal conjugate vaccines in reducing childhood mortality and morbidity when deployed in sub-Saharan Africa.

In 1996, he was appointed to the staff of the London School of Hygiene & Tropical Medicine where he is now Manson Professor of Clinical Tropical Medicine. From 2001–2009 he directed the Gates Malaria Partnership which supported a programme of research and capacity development in many countries in Africa directed at improving treatment and prevention of malaria and from 2009-2016 he directed the Malaria Capacity Development Consortium (MCDC) which supported postgraduate training in malaria research in five African universities. More recently he has supported the establishment of a trial site in Kambia district, Sierra Leone, where an Ebola vaccine is being evaluated.

Last updated: 9 August 2016